MINNEAPOLIS, March 18, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its
2018 financial results will be released after market close on Tuesday, March 19th. DiaMedica’s management will host a live
conference call on Wednesday, March 20th at 8:00am Central Time to provide a business update and discuss the Company’s
financial results.
Conference Call details:
Listeners should log on to the website or dial in 15 minutes prior to the call. The webcast will remain
available for play back on our website, under investor events and presentations, following the earnings call and for 12 months
thereafter. A telephonic replay of the conference call will be available until March 28, 2019, by dialing 1(855) 859-2056 (US
Toll Free Dial In), (404) 537-3406 (international), replay passcode 6773627.
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments
for chronic kidney diseases and neurological disorders. The Company currently has an ongoing phase II study in acute ischemic
stroke and a phase Ib study in chronic kidney disease. DiaMedica’s shares are listed on The Nasdaq Capital Market under the trading
symbol “DMAC.”
For more information, please visit www.diamedica.com.
Contact:
Scott Kellen
Chief Financial Officer
Phone: (763) 496-5118
skellen@diamedica.com
Paul Papi
Vice President of Business Development
Phone: (617) 899-5941
info@diamedica.com
